Thyroid Cancer

Thyroid cancer, which is more common in women than in men, is treated by expert teams within our thyroid tumor centers that include endocrinologists, surgeons, pathologists, medical oncologists and radiation oncologists who evaluate each person's cancer and incorporate the latest knowledge and pioneering technology in their treatment plans.

Johns Hopkins experts have moved the field forward with their innovations in detecting thyroid cancer, pioneering new treatments for the disease working with patients who have inherited forms of it. Johns Hopkins was the first hospital to offer transoral robotic thyroid surgery, and is one of only a few centers in the US to offer scarless thyroidectomy and parathyroidectomy.

Most types of thyroid cancer have a good prognosis and, for more advanced cancers, seeking expert care at Johns Hopkins offers access to clinical trials that may eventually set new standards of care.

Thyroid Cancer: What You Need to Know

Thyroid cancer represented 3.8% of all new cancer cases in the United States.
There are an estimated 64,300 new cases of thyroid cancer in 2016.
Thyroid cancer is most frequently diagnosed among people 45-54 years of age.
Approximately 1.1 percent of men and women will be diagosed with thyroid cancer at some point during their lifetime.